|
FAM60A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.997600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.186600E-01 |
| Normal-vs-Stage2 |
9.168400E-01 |
| Normal-vs-Stage3 |
3.547000E-01 |
| Normal-vs-Stage4 |
1.800750E-01 |
| Stage1-vs-Stage2 |
7.583800E-01 |
| Stage1-vs-Stage3 |
4.669200E-01 |
| Stage1-vs-Stage4 |
2.854200E-01 |
| Stage2-vs-Stage3 |
4.575800E-01 |
| Stage2-vs-Stage4 |
2.137000E-01 |
| Stage3-vs-Stage4 |
6.406400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.714800E-01 |
| Normal-vs-AfricanAmerican |
2.828800E-01 |
| Normal-vs-Asian |
8.510200E-01 |
| Caucasian-vs-AfricanAmerican |
5.936000E-01 |
| Caucasian-vs-Asian |
8.784600E-01 |
| AfricanAmerican-vs-Asian |
7.185600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.127800E-01 |
| Normal-vs-Female |
2.357400E-01 |
| Male-vs-Female |
3.062600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.659400E-01 |
| Normal-vs-Extreme_Weight |
8.848400E-01 |
| Normal-vs-Obese |
1.944990E-01 |
| Normal-vs-Extreme_Obese |
6.037000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.779200E-01 |
| Normal_Weight-vs-Obese |
1.942430E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.090000E-01 |
| Extreme_Weight-vs-Obese |
1.420650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.497200E-01 |
| Obese-vs-Extreme_Obese |
1.764230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.397690E-02 |
| Normal-vs-Age(41-60Yrs) |
1.667250E-01 |
| Normal-vs-Age(61-80Yrs) |
9.027200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.583810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.593600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.299100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.363300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.743900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.358500E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.514000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.357240E-01 |
| Normal-VS-Type2 PRCC |
6.138200E-02 |
| Normal-VS-KIRP CIMP |
2.264800E-03 |
| Normal-VS-Unclassified PRCC |
1.975240E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.6578999999517E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.676200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.951000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.42979999962334E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.498700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.062980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.152600E-01 |
| Normal-vs-N1 |
5.008400E-02 |
| Normal-vs-N2 |
2.026000E-01 |
| N0-vs-N1 |
1.740950E-03 |
| N0-vs-N2 |
7.575800E-02 |
| N1-vs-N2 |
8.434600E-01 |
|
|
